Virginia O'connor, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-0333 |
James Jacob, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-0333 |
Terrence Mcdonough, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-0333 |
Edward Mcdonnell, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-0333 |
Elizabeth Lawton, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 110 Willis Ave, Mineola, NY 11501 Phone: 516-294-0030 |
Lisa Lynch, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 110 Willis Ave, Mineola, NY 11501 Phone: 516-294-0030 |
Susan Fackelman, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-0333 |
Michelle Lin, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-2216 Fax: 516-663-8585 |
Tara Deitrick, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-741-0570 Fax: 516-741-8276 |
Joan Silke, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-0333 |
Maureen Curtin, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-0333 |
Shoba Sanu, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-2216 |
Mr. Frank Joseph Daugherty, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 216 1st St, Mineola, NY 11501 Phone: 516-663-2216 |
Frederick James, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-741-0570 |
Julie Evans, RN Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-741-0570 |
Mr. Mark Everett Bashford, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 216 1st St, Mineola, NY 11501 Phone: 516-741-0570 Fax: 516-741-8276 |
News Archive
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in Australia.
All Americans should be "on guard" as the Obama administration threatens religious liberty, the U.S. Conference of Catholic Bishops declared Thursday. The call to action is spelled out in a document, "Our First, Most Cherished Liberty," developed by the conference's Ad Hoc Committee on Religious Liberty.
A low dose of insulin has been found to suppress the expression in the blood of four precursor proteins involved in the pathogenesis of Alzheimer's disease, according to new clinical research by University at Buffalo endocrinologists. The research, published in March online in the Journal of Clinical Endocrinology and Metabolism, suggests that insulin could have a powerful, new role to play in fighting Alzheimer's disease.
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
Label-free technologies have entered the stage of cellular drug discovery and high-throughput screening (HTS). For the measurement of G protein-coupled receptor (GPCR) activation electrical impedance represents an excellent universal readout technology, since different signaling pathways can be measured in one assay format using recombinant as well as primary cells.
› Verified 1 days ago